ロード中...
When to start antiretroviral therapy: the need for an evidence base during early HIV infection
BACKGROUND: Strategies for use of antiretroviral therapy (ART) have traditionally focused on providing treatment to persons who stand to benefit immediately from initiating the therapy. There is global consensus that any HIV+ person with CD4 counts less than 350 cells/μl should initiate ART. However...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3682886/ https://ncbi.nlm.nih.gov/pubmed/23767777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-11-148 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|